Customize your JAMA Network experience by selecting one or more topics from the list below.
Author Affiliations:JAMA, Chicago, Ill (Drs Olson, Rennie, and Cook, Mss Flanagin and Reiling, and Mr Pace); Department of Medicine, Division of Emergency Medicine, University of Washington, Seattle (Dr Olson); Institute for Health Policy Studies, University of California, San Francisco (Dr Rennie); Departments of Medicine, Clinical Epidemiology, and Biostatistics, McMaster University, Hamilton, Ontario (Dr Cook); and Department of Community Health (Drs Dickersin and Hogan and Ms Zhu) and Center for Statistical Sciences (Dr Hogan), Brown University, Providence, RI.
Context Studies with positive results are more likely to be published than studies
with negative results (publication bias). One reason this occurs is that authors
are less likely to submit manuscripts reporting negative results to journals.
There is no evidence that publication bias occurs once manuscripts have been
submitted to a medical journal. We assessed whether submitted manuscripts
that report results of controlled trials are more likely to be published if
they report positive results.
Methods Prospective cohort study of manuscripts submitted to JAMA from February
1996 through August 1999. We classified results as positive if there was a
statistically significant difference (P<.05) reported
for the primary outcome. Study characteristics and indicators for quality
were also appraised. We included manuscripts that reported prospective studies
in which participants were assigned to an intervention or comparison group
and statistical tests compared differences between groups.
Results Among 745 manuscripts, 133 (17.9%) were published: 78 (20.4%) of 383
with positive results, 51 (15.0%) of 341 with negative results, and 4 (19.0%)
of 21 with unclear results. The crude relative risk for publication of studies
with positive results compared with negative results was 1.36 (95% confidence
interval [CI], 0.99-1.88). After being adjusted simultaneously for study characteristics
and quality indicators, the odds ratio for publishing studies with positive
results was 1.30 (95% CI, 0.87-1.96).
Conclusions Among submitted manuscripts, we did not find a statistically significant
difference in publication rates between those with positive vs negative results.
Publication bias refers to the greater likelihood that studies with
positive results will be published.1-3
Publication bias has been demonstrated in several cohort studies that followed
up protocols approved by research ethics committees,2,4,5
ongoing trials funded by the National Institutes of Health,6
medical doctoral dissertations,7 and abstracts
presented at scientific meetings.1,8
Although such studies show that researchers are more likely to submit
reports with positive results, it is less clear whether journal editors are
more likely to publish them. Researchers may assume that reports of research
with negative results will be rejected,9 but
few researchers associated with unpublished results actually submitted a manuscript.2,4,10 One case-control study11 examined 100 published and 100 rejected manuscripts
submitted to either of 2 Spanish medical journals and found no evidence for
publication bias. However, that study may have been too small to identify
a meaningful association. We are unaware of any evidence that editors are
more likely to publish studies with positive results.
Our objective was to examine whether publication bias operates in editorial
decision making. We hypothesized that editors preferentially publish studies
with positive results. We performed a prospective cohort study to learn which
manuscripts submitted to JAMA were published.
About 4000 manuscripts are submitted to JAMA annually. Each is assigned
to a reviewing editor. About half are rejected after internal review and half
undergo external peer review. Although the reviewing editor may reject a manuscript
at any point, manuscripts are accepted only by the editor-in-chief or designated
deputy. Four JAMA editors participated in this investigation; none had ultimate
responsibility for accepting manuscripts at JAMA.
Manuscripts were included in the cohort if they reported results of
a study that was prospective, assigned participants to an intervention, had
at least 1 comparison group, and used a statistical test to compare differences
in outcomes between groups. Such studies were typically randomized. Eligibility
for inclusion was assessed in 2 steps: an editor-investigator working in the JAMA
office screened all manuscripts for adherence to the first 3 criteria. Copies
of manuscripts were then sent to 2 of 3 editor-investigators, who verified
that the manuscript met all 4 criteria.
Data were abstracted during the editorial process so that investigators
were unaware of the publication status of the manuscript when they abstracted
data. Data were abstracted independently by 2 of 3 investigators who completed
data forms by consensus and forwarded them to other investigators for data
entry and analysis. Other investigators independently extracted information
on publication status from JAMA's database and sent it directly for data
entry and analysis.
Our primary outcome was publication in JAMA. The primary independent
variable was whether study results were positive, as determined by applying
previously published sequential steps.12 The
primary predictor of publication was significance of results. We classified
results as positive if they showed a statistically
significant effect (P<.05; 95% confidence interval
[CI] for difference excluding 0 or 95% CI for ratio excluding 1) on the primary
outcome in that study and negative if they did not.
If no primary outcome was stated or discernible, we classified results based
on most outcomes. Results were unclear if they could
not be classified as positive or negative, typical when many outcomes were
reported and an equal number were positive and negative but none was primary.
We abstracted information on study characteristics examined by others
for association with publication1,2,4-6,13-17
and on objective indicators of study quality and reporting transparency2,13
(Table 1). We also recorded the clinical topic, sex and age of study
participants, and the funding sources as reported in the manuscript. If an
industry supplied only drugs or devices, we did not count it as having funded
Before our investigation, JAMA editors agreed to take part in studies
relating to peer review and editorial decision making. We did not tell editors
the details of this investigation or request informed consent for participation,
since their awareness might have influenced their publication decisions.18 For several years, JAMA's Instructions to Authors
have told authors that their work might be included in a study.19
We did not tell authors about this investigation, because the standard editorial
process was unchanged and the confidentiality of the author-editor relationship
was maintained. The University of Washington's Human Subjects Review Committee
approved the protocol by waiver of consent, under the condition that investigators
inform the other editors about the study after all publication decisions had
We estimated the number of manuscripts needed for this investigation,
assuming that manuscripts with positive and negative results would be submitted
in equal proportions and the overall publication rate would be 16%. Using
a 2-sided test for significance of .05 and power of 0.80, 708 manuscripts
would be required to detect a difference between 12% and 20% publication rates.
We increased the sample size to 750 to allow for manuscripts with unclear
significance of results.
Proportions of studies published were examined by significance of results
and other variables. Associations between independent variables and publication
were estimated with relative risks (RRs) and 95% CIs. The P values were not adjusted for multiple comparisons, and P<.05 was considered statistically significant. To adjust for several
variables simultaneously, we used multiple logistic regression and calculated
the odds ratio (OR) as the measure of association. Data were entered into
an Access (version 2.0, Microsoft Corporation, Redmond, Wash) database and
analyzed with SAS software (version 6.12, SAS Institute, Cary, NC).
Since awareness of the investigation may have influenced the decision
making of the 4 JAMA editors who were also investigators, we performed additional
analyses that excluded their assigned manuscripts. Editors who were not investigators
were asked whether they had been aware of the investigation. They rated their
awareness with a continuous scale, with 0 indicating they were unaware that
any investigation was in progress, 5 indicating they knew some investigation
was in progress but were unaware that it was about publication bias, and 10
indicating they knew everything about the investigation, including its hypothesis.
From February 1996 through August 1999, 13 569 manuscripts were
submitted to JAMA; 745 met all inclusion criteria. Manuscripts were distributed
among 20 JAMA editors for primary responsibility. Among the 745 manuscripts,
383 (51.4%) had positive results, 341 (45.7%) had negative results, and 21
(2.8%) had unclear significance of results.
JAMA published 133 (17.9%) of these manuscripts: 78 (20.4%) of 383
with positive results, 51 (15.0%) of 341 with negative results, and 4 (19.0%)
of 21 with unclear significance of results. After studies with an unclear
significance of results were excluded, those with positive results were not
significantly more likely to be published (unadjusted RR, 1.36; 95% CI, 0.99-1.88).
The association of other factors with publication is shown in Table 1.
After all study characteristics and quality indicators were adjusted
for, an OR of 1.30 (95% CI, 0.87-1.96) was achieved for publishing manuscripts
with positive vs negative results
(Table 2). Being multicenter trials, enrolling in the United States, and
having a sample size calculation were significantly associated with publication
After manuscripts for which any of the investigators were editors were
excluded, the adjusted OR for publishing manuscripts with positive vs negative
results was 1.32 (95% CI, 0.84-2.07). Of the 16 JAMA editors who were not
investigators, 14 responded to the questionnaire about their awareness of
the study. The median score was 4 (range, 0-10) and the mean score was 3.7,
indicating editors were generally aware some investigation was in progress
but were unaware of its hypothesis.
Submitted manuscripts reporting results of controlled trials are not
significantly more likely to be published if they report positive results.
Studies with indicators for higher quality were more likely to be published.
In a case-control study11 of submitted manuscripts,
higher study quality was associated with publication. In contrast, methodologic
quality of abstracts, letters, short reports,13
and meta-analyses submitted to JAMA20 was
not associated with publication of full results.
We also found that studies enrolling some participants in the United
States had an increased adjusted OR of publication. Previous studies21,22 found an association between journals'
nationality and the national origin of the reports they publish. However,
those studies did not account for differences in submissions to journals by
nationality. Another study15 found that manuscripts
submitted to Gastroenterology, a US journal, were
more likely to be published if authors were from the United States. However,
that study did not adjust for quality of the submitted manuscripts.
In our investigation, a statistically significant difference (P<.05) in outcomes between groups was used to determine
a positive study. Some definitions of positive require
that the significant result favor the experimental intervention13
or be beneficial.1 Another definition is that
a positive result will change current thinking or the standard of care.3,23
Researchers may interpret our results as confirming editors' publication
bias, but any such bias is small compared with that demonstrated repeatedly
for researchers. We found an adjusted OR of 1.30 for publication of controlled
trials with positive results. A meta-analysis10
of controlled trials identified at funding or approval by an ethics committee
found an OR for publication of 5.96 (95% CI, 2.33-15.22). Although authors2,9 and others24
have assumed that editors preferentially publish manuscripts with positive
results, researchers are more likely to write and submit manuscripts for studies
with positive results.2,4,10
Editors may interpret our results as showing no evidence for publication
bias. The Declaration of Helsinki25 charges
authors and publishers to make available negative and positive results of
investigations. Registries of clinical trials26
and online journals may facilitate the reporting of trials with negative results.27 Editors must guard against basing publication on
the significance of a study's results; they should also judge manuscripts
on the clinical question addressed and quality of the research methods.28,29
Assessing the influence of reviewers on editors' decisions is difficult.
In one study,30 reviewers were no more likely
to recommend publication of manuscripts reporting positive results.
The strengths of our investigation include its large sample size, prospective
design, consideration of consecutive manuscripts submitted to a large-circulation,
high-impact, general medical journal, objective inclusion criteria, data abstraction
by 2 independent investigators blinded to publication status, and analysis
of confounding variables.
Our results may not be generalizable to manuscripts describing studies
other than controlled trials. Publication bias may affect studies of various
Our results apply specifically to the editorial process at JAMA, for a specific
period and set of editors; our findings may not be generalizable to specialty
journals or journals with fewer submissions, fewer editors, or lower circulation.32
We accrued more manuscripts than required under the assumptions of our
sample-size calculation. The difference in publication rates (5.4%) was smaller
than we hypothesized (8%), decreasing power to detect a difference between
groups. In addition, adjusting for covariates decreased the power to detect
publication bias.33 We used a conservative
2-sided test for significance, which allows for the possibility that studies
with negative results are published at a higher rate than studies with positive
results; using 1-sided tests for our analysis would have given statistically
Olson CM, Rennie D, Cook D, et al. Publication Bias in Editorial Decision Making. JAMA. 2002;287(21):2825–2828. doi:10.1001/jama.287.21.2825
Browse and subscribe to JAMA Network podcasts!
Create a personal account or sign in to: